Phase 2 Hidradenitis Suppurativa Clinical Trials
15 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–15 of 15 trials
Recruiting
Phase 2
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
Hidradenitis Suppurativa
Pfizer240 enrolled54 locationsNCT07228390
Recruiting
Phase 2
Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Sinocelltech Ltd.60 enrolled1 locationNCT07244510
Recruiting
Phase 2
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
Sanofi144 enrolled43 locationsNCT07225569
Recruiting
Phase 2
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
Sanofi208 enrolled69 locationsNCT07170917
Recruiting
Phase 2
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Incyte Corporation40 enrolled27 locationsNCT07213973
Recruiting
Phase 2Phase 3
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Bluefin Biomedicine, Inc.210 enrolled33 locationsNCT07287644
Recruiting
Phase 2
A Study With CIT-013 in HS Patients
Hidradenitis Suppurativa (HS)
Citryll BV96 enrolled24 locationsNCT06993233
Recruiting
Phase 2
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Takeda90 enrolled49 locationsNCT07244263
Recruiting
Phase 2
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Hidradenitis Suppurativa (HS)
Zura Bio Inc225 enrolled56 locationsNCT06993610
Recruiting
Phase 2
The Safety and Efficacy of Roflumilast Foam in HS
Hidradenitis Suppurativa (HS)
Beth Israel Deaconess Medical Center20 enrolled1 locationNCT07263230
Recruiting
Phase 2
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Navigator Medicines, Inc.150 enrolled10 locationsNCT07384975
Recruiting
Phase 1Phase 2
Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.
Hidradenitis Suppurativa
Shanghai Huaota Biopharmaceutical Co., Ltd.15 enrolled1 locationNCT06895499
Recruiting
Phase 2
A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa
Hidradenitis Suppurativa
Tulane University10 enrolled4 locationsNCT07077902
Recruiting
Phase 2
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
Atopic DermatitisHidradenitis Suppurativa
AbbVie60 enrolled2 locationsNCT06524635
Recruiting
Phase 2
Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
Hidradenitis Suppurativa
Milton S. Hershey Medical Center24 enrolled1 locationNCT04414514